Report Detail

Pharma & Healthcare Global DNA & RNA Oligonucleotides Market Size, Status and Forecast 2021-2027

  • RnM4297894
  • |
  • 01 April, 2021
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 DNA Oligonucleotides
    • 1.2.3 RNA Oligonucleotides
  • 1.3 Market by Application
    • 1.3.1 Global DNA & RNA Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals and Clinics
    • 1.3.3 Biopharma Companies
    • 1.3.4 Academic & Research Organizations
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global DNA & RNA Oligonucleotides Market Perspective (2016-2027)
  • 2.2 DNA & RNA Oligonucleotides Growth Trends by Regions
    • 2.2.1 DNA & RNA Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 DNA & RNA Oligonucleotides Historic Market Share by Regions (2016-2021)
    • 2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Regions (2022-2027)
  • 2.3 DNA & RNA Oligonucleotides Industry Dynamic
    • 2.3.1 DNA & RNA Oligonucleotides Market Trends
    • 2.3.2 DNA & RNA Oligonucleotides Market Drivers
    • 2.3.3 DNA & RNA Oligonucleotides Market Challenges
    • 2.3.4 DNA & RNA Oligonucleotides Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
    • 3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2016-2021)
    • 3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2016-2021)
  • 3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue
  • 3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
    • 3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2020
  • 3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served
  • 3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service
  • 3.7 Date of Enter into DNA & RNA Oligonucleotides Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 DNA & RNA Oligonucleotides Breakdown Data by Type

  • 4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2016-2021)
  • 4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2022-2027)

5 DNA & RNA Oligonucleotides Breakdown Data by Application

  • 5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2016-2021)
  • 5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America DNA & RNA Oligonucleotides Market Size (2016-2027)
  • 6.2 North America DNA & RNA Oligonucleotides Market Size by Type
    • 6.2.1 North America DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
    • 6.2.2 North America DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
    • 6.2.3 North America DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
  • 6.3 North America DNA & RNA Oligonucleotides Market Size by Application
    • 6.3.1 North America DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
    • 6.3.2 North America DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
    • 6.3.3 North America DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
  • 6.4 North America DNA & RNA Oligonucleotides Market Size by Country
    • 6.4.1 North America DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
    • 6.4.2 North America DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe DNA & RNA Oligonucleotides Market Size (2016-2027)
  • 7.2 Europe DNA & RNA Oligonucleotides Market Size by Type
    • 7.2.1 Europe DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
    • 7.2.2 Europe DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
    • 7.2.3 Europe DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
  • 7.3 Europe DNA & RNA Oligonucleotides Market Size by Application
    • 7.3.1 Europe DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
    • 7.3.2 Europe DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
    • 7.3.3 Europe DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
  • 7.4 Europe DNA & RNA Oligonucleotides Market Size by Country
    • 7.4.1 Europe DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
    • 7.4.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2016-2027)
  • 8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type
    • 8.2.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application
    • 8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
    • 8.4.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America DNA & RNA Oligonucleotides Market Size (2016-2027)
  • 9.2 Latin America DNA & RNA Oligonucleotides Market Size by Type
    • 9.2.1 Latin America DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
    • 9.2.2 Latin America DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
    • 9.2.3 Latin America DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
  • 9.3 Latin America DNA & RNA Oligonucleotides Market Size by Application
    • 9.3.1 Latin America DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
    • 9.3.2 Latin America DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
    • 9.3.3 Latin America DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
  • 9.4 Latin America DNA & RNA Oligonucleotides Market Size by Country
    • 9.4.1 Latin America DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
    • 9.4.2 Latin America DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2016-2027)
  • 10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type
    • 10.2.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application
    • 10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
    • 10.4.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Eurofins Scientific
    • 11.1.1 Eurofins Scientific Company Details
    • 11.1.2 Eurofins Scientific Business Overview
    • 11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
    • 11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.1.5 Eurofins Scientific Recent Development
  • 11.2 Natera
    • 11.2.1 Natera Company Details
    • 11.2.2 Natera Business Overview
    • 11.2.3 Natera DNA & RNA Oligonucleotides Introduction
    • 11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.2.5 Natera Recent Development
  • 11.3 BGI
    • 11.3.1 BGI Company Details
    • 11.3.2 BGI Business Overview
    • 11.3.3 BGI DNA & RNA Oligonucleotides Introduction
    • 11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.3.5 BGI Recent Development
  • 11.4 Illumina
    • 11.4.1 Illumina Company Details
    • 11.4.2 Illumina Business Overview
    • 11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
    • 11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.4.5 Illumina Recent Development
  • 11.5 Roche
    • 11.5.1 Roche Company Details
    • 11.5.2 Roche Business Overview
    • 11.5.3 Roche DNA & RNA Oligonucleotides Introduction
    • 11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.5.5 Roche Recent Development
  • 11.6 LabCorp
    • 11.6.1 LabCorp Company Details
    • 11.6.2 LabCorp Business Overview
    • 11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
    • 11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.6.5 LabCorp Recent Development
  • 11.7 Berry Genomics
    • 11.7.1 Berry Genomics Company Details
    • 11.7.2 Berry Genomics Business Overview
    • 11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
    • 11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.7.5 Berry Genomics Recent Development
  • 11.8 Brooks Life Sciences
    • 11.8.1 Brooks Life Sciences Company Details
    • 11.8.2 Brooks Life Sciences Business Overview
    • 11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
    • 11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.8.5 Brooks Life Sciences Recent Development
  • 11.9 Macrogen
    • 11.9.1 Macrogen Company Details
    • 11.9.2 Macrogen Business Overview
    • 11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
    • 11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.9.5 Macrogen Recent Development
  • 11.10 Genotypic Technology
    • 11.10.1 Genotypic Technology Company Details
    • 11.10.2 Genotypic Technology Business Overview
    • 11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
    • 11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.10.5 Genotypic Technology Recent Development
  • 11.11 Dna Link
    • 11.11.1 Dna Link Company Details
    • 11.11.2 Dna Link Business Overview
    • 11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
    • 11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2016-2021)
    • 11.11.5 Dna Link Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global DNA & RNA Oligonucleotides Scope and Market Size
    DNA & RNA Oligonucleotides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA & RNA Oligonucleotides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    DNA Oligonucleotides
    RNA Oligonucleotides

    Segment by Application
    Hospitals and Clinics
    Biopharma Companies
    Academic & Research Organizations
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Eurofins Scientific
    Natera
    BGI
    Illumina
    Roche
    LabCorp
    Berry Genomics
    Brooks Life Sciences
    Macrogen
    Genotypic Technology
    Dna Link


    Summary:
    Get latest Market Research Reports on DNA & RNA Oligonucleotides. Industry analysis & Market Report on DNA & RNA Oligonucleotides is a syndicated market report, published as Global DNA & RNA Oligonucleotides Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of DNA & RNA Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,844.29
    4,266.43
    5,688.58
    3,276.83
    4,915.24
    6,553.65
    427,810.50
    641,715.75
    855,621.00
    291,607.68
    437,411.52
    583,215.36
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report